Evidence map›Paper›PMID 32358059›Full record

ArticleThe Journal of biological chemistry2020

The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.

Van T Hoang, Katherine Nyswaner, Pedro Torres-Ayuso, John Brognard

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Van T HoangLaboratory of Cell and Developmental Signaling, National Cancer Institute, Frederick, Maryland, USA.
Katherine NyswanerLaboratory of Cell and Developmental Signaling, National Cancer Institute, Frederick, Maryland, USA.
Pedro Torres-AyusoLaboratory of Cell and Developmental Signaling, National Cancer Institute, Frederick, Maryland, USA.
John BrognardLaboratory of Cell and Developmental Signaling, National Cancer Institute, Frederick, Maryland, USA john.brognard@nih.gov.
National Cancer Institute · US

Funding

Oncogenic Kinases in CancerZIABC011691 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI BROGNARD, JOHN · 2016 to 2025
$14.4M
Intramural NIH HHS ZIA BC011691
6 · The paper itself

Abstract

Identifying additional mitogen-activated protein kinase (MAPK) pathway regulators is invaluable in aiding our understanding of the complex signaling networks that regulate cellular processes, including cell proliferation and survival. Here, using

Indexed as

Cell Line, TumorCell SurvivalDrug Resistance, NeoplasmHumansJNK Mitogen-Activated Protein KinasesLung NeoplasmsMAP Kinase Kinase KinasesMAP Kinase Signaling SystemMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase KinasesPhosphorylationProtein Kinase InhibitorsProto-Oncogene MasProto-Oncogene Proteins c-rafProto-Oncogene Proteins p21(ras)JNK Mitogen-Activated Protein KinasesMAP3K19 protein, humanMAP Kinase Kinase KinasesMAS1 protein, humanMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase KinasesProtein Kinase InhibitorsProto-Oncogene MasProto-Oncogene Proteins c-rafProto-Oncogene Proteins p21(ras)RNA, Small Interferingcell proliferationc-Jun N-terminal kinase (JNK)extracellular-signal-regulated kinase (ERK)GTPase Kras (KRAS)kinase signalingkinomelung cancermitogen-activated protein kinase kinase kinase 19 (MAP3K19)oncogeneprotein kinaseYSK4

Identifiers

PMID32358059
PMCPMC7307187
OpenAlexW3023126964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.